Last $2.25 USD
Change Today -0.03 / -1.32%
Volume 33.5K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tom Smart

Former Senior Vice President - Corporate Development, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 48 board members in 2 different organizations across 3 different industries.

See Board Relationships
50--

Background*

Mr. Thomas E. Smart, Tom served as Executive Chairman and Chief Executive Officer of Anaptys Biosciences, Inc., since April 2007. Mr. Smart served as Senior Vice President of Corporate Development of GenVec Inc., where he was responsible for directing GenVec Inc. business development, intellectual property and contracting functions. He served with GenVec Inc. from March 1995 to April 2003. He served as Chief Business Officer of XOMA Ltd. Since August 2003, Mr. Smart ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

Director
Former Executive Chairman and Chief Executive Officer
2004-Present
Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Research and Development Committee

Education*

MBA
The University of Chicago
BS
Cornell University
MBA
The University of Chicago Booth School of Business
Unknown/Other Education
Stanford Graduate School of Business
Unknown/Other Education
Stanford University Law school

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.25 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.